1. Association and CpG SNP analysis of HTR4 polymorphisms with suicidal behavior in subjects with schizophrenia

   • Gina Polsinelli
   • Clement C. Zai
   • Vincenzo De Luca

   Basic Neurosciences, Genetics and Immunology - Original Article 29 July 2012 Pages: 253 - 258

   

2. Long-term decrease in immediate early gene expression after electroconvulsive seizures

   • Julien Braga Calais
   • Samira S. Valvassori
   • Elida Benquique Ojopi

   Basic Neurosciences, Genetics and Immunology - Original Article 09 August 2012 Pages: 259 - 266

   

3. Ganglionic blockade alters behavioral and cerebral metabolic responses to corticotropin releasing factor in the rat

   • Ulderico Freo
   • Carlo Ori

   Basic Neurosciences, Genetics and Immunology - Original Article 26 July 2012 Pages: 267 - 274

   

4. Immunogenicity of botulinum toxins

   • Markus Naumann
   • Lee Ming Boo
   • Conor J. Gallagher

   Translational Neurosciences - Review article Open access 25 September 2012 Pages: 275 - 290

5. Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations

   • M. Brown
   • G. Nicholson
   • J. Francis

   Basic Neurosciences, Genetics and Immunology - Original Article 29 July 2012 Pages: 291 - 298

   

6. AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies

   • Robert A. Hauser
   • Daniel Truong
   • Philippe Picaut

   Neurology and Preclinical Neurological Studies - Original Article 10 August 2012 Pages: 299 - 307

   

7. Levodopa increases speed of alternating movements in Parkinson’s disease patients

   • Thomas Müller
   • Sören Peters
   • Ali Harati

   Movement Disorders - Short communication 22 June 2012 Pages: 309 - 313

   

8. Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson’s disease under duodopa^® therapy

   • Sabine Skodda
   • Thomas Müller

   Movement Disorders - Short communication 14 July 2012 Pages: 315 - 318

   

9. Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy

   • Jan Rusz
   • Roman Čmejla
   • Evžen Růžička

   Movement Disorders - Original Article 08 July 2012 Pages: 319 - 329

   

10. Anticoagulants versus antiplatelets for carotid artery dissection

    • Natan M. Bornstein

    Editorial 05 January 2013 Pages: 331 - 331

    

11. Anticoagulants versus antiplatelet drugs for cervical artery dissection: case for anticoagulants

    • John W. Norris

    Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 13 December 2012 Pages: 333 - 334

12. Why antiplatelet treatment in spontaneous internal carotid dissection?

    • O. Bajenaru
    • C. Tiu
    • F. Antochi

    Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 11 December 2012 Pages: 335 - 338

    

13. Steroids in bacterial meningitis: yes

    • Felix Benninger
    • Israel Steiner

    Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 13 December 2012 Pages: 339 - 342

14. Controversies in neurology, Vienna, 2012: Steroids in bacterial meningitis: no

    • Bettina Pfausler
    • Erich Schmutzhard

    Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 20 December 2012 Pages: 343 - 346

15. Is there room for non-dopaminergic treatment in Parkinson disease?

    • Abraham Lieberman
    • Narayanan Krishnamurthi

    Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 16 December 2012 Pages: 347 - 348

16. Is there room for new non-dopaminergic treatments in Parkinson’s disease?

    • Manuela Pilleri
    • Konstantinos Koutsikos
    • Angelo Antonini

    Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 11 December 2012 Pages: 349 - 352

17. Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer’s disease

    • Wei-wei Chang
    • Liu Zhang
    • Ying-shui Yao

    Dementias - Review article 11 July 2012 Pages: 353 - 360